SKI Market

A+| A| A-|

Indian Indices

Sensex

77,496.36 609.45
( 0.79%)

Global Indices

Nasdaq

49,166.29 -22.51
(-0.05%)

Dow Jones

7,159.57 -35.34
(-0.49%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,208.73 -124.06
(-1.20%)

Forex

USD-INR

94.18 0.27
(0.28%)

EUR-INR

110.46 0.44
(0.40%)

GBP-INR

127.53 0.53
(0.42%)

JPY-INR

0.59 0.00
(0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

595.4947465

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

19.03

105247.2

EPS(TTM)

Face Value()

Div & Yield %

120.95

0.52

Back

Dynavision consolidated net profit rises 33.33% in the December 2025 quarter

Feb 13,2026

Net profit of Dynavision rose 33.33% to Rs 1.40 crore in the quarter ended December 2025 as against Rs 1.05 crore during the previous quarter ended December 2024. Sales rose 4.73% to Rs 3.32 crore in the quarter ended December 2025 as against Rs 3.17 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	3.32	3.17	5
OPM %	76.20	74.76	-
PBDT	2.49	2.00	25
PBT	1.92	1.44	33
NP	1.40	1.05	33

77,496.36 609.45 ( 0.79%)

49,166.29 -22.51 (-0.05%)

7,159.57 -35.34 (-0.49%)

59,839.06 -698.30 (-1.15%)

10,208.73 -124.06 (-1.20%)

94.18 0.27 (0.28%)

110.46 0.44 (0.40%)

127.53 0.53 (0.42%)

0.59 0.00 (0.34%)